Drug Shortage Report for ACETAZOLAMIDE FOR INJECTION, USP
| Report ID | 188809 |
| Drug Identification Number | 02358328 |
| Brand name | ACETAZOLAMIDE FOR INJECTION, USP |
| Common or Proper name | ACETAZOLAMIDE FOR INJECTION, USP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ACETAZOLAMIDE |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 VIAL |
| ATC code | S01EC |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2024-06-01 |
| Actual start date | |
| Estimated end date | 2027-01-01 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-01-23 |
| Company comments | Product is currently not available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-05-02 | French | Compare |
| v3 | 2023-05-02 | English | Compare |
| v2 | 2023-04-05 | French | Compare |
| v1 | 2023-04-05 | English | Compare |